Report Summary 1. Industry Investment Rating No industry investment rating information is provided in the report. 2. Core View The report regularly tracks the latest private exchangeable bond (private EB) projects from public channels, providing basic element tracking for private exchangeable bond projects. It emphasizes that the private issuance terms and processes may change, and the final prospectus should be referred to. For the issuance progress, inquiries should be made with the relevant lead underwriters [1]. 3. Weekly New Project Information - **HuaBang Life Science Co., Ltd.**: In 2026, the project of privately issuing science - and - technology innovation exchangeable corporate bonds to professional investors was approved by the exchange. The proposed issuance scale is 1 billion yuan, the underlying stock is Kaisheng New Materials (301069.SZ), the lead underwriters are Huatai United and Southwest Securities, and the exchange update date is March 3, 2026 [1]. - **Liaoning Chengda Co., Ltd.**: In 2026, the project of privately issuing exchangeable corporate bonds to professional investors was accepted by the exchange. The proposed issuance scale is 4 billion yuan, the underlying stock is GF Securities (000776.SZ), the lead underwriter is CITIC Construction Securities, and the exchange update date is March 4, 2026 [1]. 4. Table of Private EB Weekly Tracking (2026 - 3 - 6) The table lists information on multiple private exchangeable bond projects, including bond names, lead underwriters, scales, underlying stocks, project statuses, and update dates. Projects are in different statuses such as "Passed", "Feedback Received", and "Accepted" [3].

Core Viewpoint - The report highlights the performance and positioning of the Guotai Xinyi One-Year Holding Period Mixed A Fund (008666) for the fourth quarter of 2025, indicating a modest profit and a stable fund size amidst market fluctuations. Fund Performance - The fund reported a profit of 251,000 yuan in the fourth quarter, with a weighted average profit per fund share of 0.0036 yuan [3] - The fund's net value growth rate for the reporting period was 0.3%, with a total fund size of 81.8903 million yuan as of the end of the fourth quarter [3][14] - As of January 21, the unit net value was 1.233 yuan [3] Comparative Performance - Over the past three months, the fund's net value growth rate was 1.51%, ranking 395 out of 629 comparable funds [4] - The fund's six-month growth rate was 4.50%, ranking 295 out of 629 [4] - The one-year growth rate was 7.43%, ranking 319 out of 626 [4] - The three-year growth rate was 11.53%, ranking 288 out of 564 [4] Risk and Return Metrics - The fund's Sharpe ratio over the past three years was 0.7557, ranking 221 out of 542 comparable funds [8] - The maximum drawdown over the past three years was 4.39%, with a ranking of 147 out of 526 [10] - The single-quarter maximum drawdown occurred in Q3 2022, at 2.67% [10] Investment Strategy - The average stock position over the past three years was 13%, compared to the industry average of 19.2% [13] - The fund reached a peak stock position of 22.54% in mid-2020 and a low of 6.95% at the end of 2023 [13] - In Q4, the fund reduced its equity position to manage market volatility, maintaining a balanced allocation in sectors such as power equipment, chemicals, and high-dividend stocks [3] Top Holdings - As of the end of Q4 2025, the fund's top ten holdings included major companies such as Industrial and Commercial Bank of China, Shanghai Pudong Development Bank, and China Mobile [17]

Core Viewpoint - Multiple companies have issued risk warnings regarding their stock performance, indicating potential irrational market speculation and volatility risks due to significant recent price increases [1][4][8]. Group 1: Company Announcements - Pingtan Development announced that its stock price has surged over 220% since October 17, with a market capitalization increase from 6.5 billion to 21 billion [5]. - Gohome China reported a 256.29% cumulative increase in stock price over 14 trading days, with 12 days closing at the daily limit, and highlighted the risk of market sentiment overheating [2][3]. - Suning Pharmaceutical is advancing several clinical trials for innovative drugs, but the outcomes remain uncertain, posing risks to its stock performance [6][7]. Group 2: Market Conditions - Gohome China's static P/E ratio reached 343.67, significantly higher than the industry average of 30.94, indicating a potential valuation bubble [3]. - Several companies, including Dongbai Group and Renmin Tongtai, have also warned of trading risks due to abnormal stock price fluctuations and market sentiment [8][9]. - The Shanghai Stock Exchange has taken regulatory measures against abnormal trading behaviors, monitoring stocks with significant price volatility [3].

Group 1 - The chemical sector showed strong performance on September 5, with the Chemical ETF (516020) rising by 1.7% and reaching a peak increase of 2.13% during trading [1][2] - Key stocks in the sector included Tianqi Materials and Duofu Duo, both hitting the daily limit, while Enjie and Lianhong Xinke saw increases of over 6% and 5% respectively [1][2] - Since early July, the Chemical ETF has gained 16.13%, outperforming major indices like the Shanghai Composite Index (9.33%) and the CSI 300 Index (10.9%) [1][3] Group 2 - The chemical industry is expected to benefit from a gradual recovery in demand as policy stimuli take effect and terminal industries show signs of improvement [3][4] - The "anti-involution" policy is seen as a significant guiding principle for the manufacturing sector, aiming to eliminate unfair competition and improve the chemical industry's conditions [4][5] - The Chemical ETF's price-to-book ratio is currently at 2.16, indicating a relatively low valuation compared to historical levels, suggesting potential for long-term investment [4][5] Group 3 - Analysts suggest that the chemical sector may experience a phase of improvement as the "anti-involution" measures reduce excessive competition and capacity duplication [5] - The chemical industry in China is positioned to fill gaps in the international supply chain due to its cost advantages and technological advancements [5] - The Chemical ETF (516020) provides a diversified investment opportunity across various sub-sectors, with significant holdings in leading companies like Wanhua Chemical and Salt Lake Co [5]